OpenVSafe by OpenVAERS
Search V-safe

55F-11786-85132

1 vaccination 1 coded response 11 check-ins 1 free-text entry 1 call case
Sex
—
Age at first dose
26-30
ZIP prefix
554 / MN
Registered
2021-04-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-10
    Registered in v-safe
  2. 2021-04-10
    Dose 1 — Janssen/Johnson & Johnson
  3. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  4. 2021-04-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  5. 2021-04-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-04-17
    Health check-in — day 7, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-04-24
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-05-01
    Health check-in — day 21, single dose
    Feeling: Good
    Adult check-in
  9. 2021-05-10
    Health check-in — day 28, single dose
    Feeling: Good
    Adult check-in
  10. 2021-05-17
    Health check-in — day 35, single dose
    Feeling: Good
    Adult check-in
  11. 2021-05-25
    Health check-in — day 42, single dose
    Feeling: Fair
    Adult check-in
  12. 2021-07-12
    Health check-in — 3 months, dose 1
    Feeling: Fair
    Adult check-in
  13. 2022-04-13
    Survey response — 12 months, dose 1
    MedDRA: Asthenia, Bronchitis, COVID-19, Cough, Fatigue, Pulmonary sensitisation, Pyrexia, Respiratory disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: COVID 19 and subsequent bronchitis for five weeks. Fever, fatigue, coughing, breathing problems, sensitive lungs, lack of stamina
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-04-13
    Report sent to call center — 12 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  15. 2022-04-21

Vaccinations

DoseDateManufacturerCo-administered
12021-04-10Janssen/Johnson & Johnson

Call center

ReportedOutcomeVAERS-related outcome
2022-04-13 Unsuccessful

Free text

Release 11 — 12 months, dose 1

2022-04-13

Symptoms: COVID 19 and subsequent bronchitis for five weeks. Fever, fatigue, coughing, breathing problems, sensitive lungs, lack of stamina

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthenia · · ✓
SDBronchitis · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDFatigue · · ✓
SDPulmonary sensitisation · · ✓
SDPyrexia · · ✓
SDRespiratory disorder · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release